Fig. 5
From: Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
A Different therapeutic forms of miRNA. B Exosome mediated miR-155 inhibitor delivery to treat cisplatin-resistance oral squamous cell carcinoma [104]. C Apo-A1-modified exosomes loaded miR-26a selectively bound to HepG2 cells via the SR-B1 receptor-mediated endocytosis [21]. D Engineered exosome packaged miR-21i and chemotherapeutics 5-Fluorouracil (5-FU) to target 5-FU-resistant colorectal cancer cell [107]